:: CLDF ::

1.	Age-period-cohort and bayesian age-period-cohort prediction modeling of hepatitis C incidence and mortality in China.
	Lin, Fei (F);Liu, Zhenzhou (Z);Zhai, Jianli (J);Yi, Shibei (S);Li, Yanyan (Y);Wang, Yongbin (Y);

Local data for local programming: Results from an HIV biobehavioral survey among people who inject drugs in Livingstone, Lusaka, and Ndola, Zambia, 2021.

Woytowich, Daniel (D);McIntyre, Anne F (AF);Solomon, Hiwote (H);Hanunka, Brave (B);Chelu, Lazarus (L);Nkumbula, Tepa (T);Tally, Leigh (L);Handema, Ray (R);Khondowe, Shepherd (S);Kapungu, Kelvin (K);Chilukutu, Lophina (L);Bwalya, Innocent (I);Mulemfwe, Chipili (C);Mwansa, Melvin (M);Mutale, Kennedy (K);Philip, Neena M (NM);Reid, Giles (G);Neal, Joyce J (JJ);Lahuerta, Maria (M);Parmley, Lauren E (LE);Chung, Hannah (H);Hakim, Avi J (AJ);Hines, Jonas Z (JZ);Kim, Evelyn (E);Mwale, John (J);Mulenga, Lloyd B (LB);

3.	Discreet but accessible: a qualitative study with people who use drugs and service staff about the optimal design of a harm reduction vending machine in rural Kentucky.
	Marschke, Rachel M (RM);Young, April M (AM);Knudsen, Hannah K (HK);Cheatom, Chelsi N (CN);Cooper, Hannah L F (HLF);

4.	Utilizing Theory of Planned Behaviour to increase intention to participate in hepatitis C treatment therapy among Methadone maintenance therapy clients (MMT) in Malaysia: A cluster randomised control trial.
	Baharudin, Mohd Hafiidz (MH);Mokhtar, Siti Aisah (SA);Azman, Ahmad Zaid Fattah (AZF);Mohd Nazan, Ahmad Iqmer Nashriq (AIN);

5.	Simplified and Integrated Hepatitis C Virus Testing and Treatment Algorithm for Unhoused People Who Inject Drugs.
	Ramers, Christian B (CB);Vawter, Natalie (N);Northrup, Adam (A);Klaman, Stacey L (SL);Lewis, Sydney V (SV);Tam, Aaron (A);Del Aguila, Carolina (C);Lewis, Robert (R);Mendez, Blanca (B);Reyes, Letty (L);Matthews, Eva (E);Rojas, Sarah (S);Godino, Job G (JG);

6.	Immunohistochemical expression of PD1, LAG3, and CTLA4 in diffuse large B cell lymphoma, clinicopathological correlation, and prognostic value.
	William, Madonna I (MI);Tantawy, Dina A (DA);Elsergany, Alyaa R (AR);El-Hawary, Amira K (AK);Yussif, Shaimaa M (SM);

7.	Oral manifestations in patients with chronic hepatitis C.
	Brzd?k, Micha? (M);Ga?uszka-Garnuszek, Joanna (J);Dobrowolska, Krystyna (K);Brzd?k, Kinga (K);Janczura, Jakub (J);Tronina, Olga (O);Kal, Magdalena (M);St?pie?, Piotr (P);Zar?bska-Michaluk, Dorota (D);

8.	Impact of hepatitis C virus genotype on the efficacy of the direct-acting antivirals in chronic kidney disease patients in West Bengal, India.
	Bakshi, Sagnik (S);Dutta, Supradip (S);Biswas, Aritra (A);Das, Raina (R);Nath, Shreyasi (S);Ghosh, Anwesha (A);Baskey, Upasana (U);Sadhukhan, Provash Chandra (PC);

9.	Hepatitis C Testing in the US Veterans Health Administration: Uptake of United States Preventive Services Taskforce Universal Hepatitis C Screening Guidance.
	Varley, Cara D (CD);Beste, Lauren A (LA);Lowy, Elliott (E);Morgan, Timothy R (TR);Ross, David B (DB);Maier, Marissa M (MM);

10.	The macroeconomic burden of hepatitis C and the economic benefit of accelerated investments in China.
	Bao, Yun (Y);Chen, Ying (Y);Jin, Huajie (H);Zhang, Chi (C);Zhang, Lingli (L);Wu, Bin (B);

11.	Prescribing direct-acting antivirals for hepatitis C treatment: a scoping review of factors that influence primary care providers.
	Hallett, Jonathan (J);Price, Tina (T);Gray, Corie (C);Rosenberg, Shoshana (S);Lobo, Roanna (R);Crawford, Gemma (G);

12.	Rapid onset of neurological symptoms in an HIV-positive patient with progressive multifocal leukoencephalopathy: a case report.
	Waqas, Sameeka (S);Iqbal, Umer (U);Khurram, Laiba (L);Saleem, Ahmed (A);Ain, Qurrat Ul (QU);Butt, Mujeeb-Ur-Rehman Abid (MA);Okon, Inibehe Ime (II);

13.	Abnormal Trabecular and Cortical Bone Microarchitecture in Chronic Hepatitis C Infection and Associations With Select Inflammatory Cytokines.
	Weinstein, Erica J (EJ);Carbonari, Dean M (DM);Newcomb, Craig W (CW);Torgersen, Jessie (J);Smith, Shanae M (SM);Brecker, Katherine L (KL);Liu, X Sherry (XS);Kostman, Jay R (JR);Trooskin, Stacey (S);Hubbard, Rebecca A (RA);Baker, Joshua F (JF);Zemel, Babette S (BS);Leonard, Mary B (MB);Lo Re, Vincent (V);

14.	Incidence, Patient-Directed Discharge, Readmission, and Mortality Among People Hospitalized With Injecting-Related Infection: A Population-Based Linkage Study.
	Masters, Jeffrey (J);Jacka, Brendan (B);Barault, Marion (M);Goodman-Meza, David (D);Russell, Danielle (D);Matthews, Gail V (GV);Dore, Gregory J (GJ);Valerio, Heather (H);Martinello, Marianne (M);

15.	Prevalence-based screening by anti-HCV reflex HCV antigen test and accessible post-screening care towards elimination of hepatitis C in rural villages.
	Pan, Kuan-Chen (KC);Hsu, Nien-Tzu (NT);Tang, Ying-Mei (YM);Lee, Yu-Chen (YC);Kuo, Hsiu-Ling (HL);Huang, Tung-Jung (TJ);Tseng, Chun-Mei (CM);Lu, Sheng-Nan (SN);Chang, Te-Sheng (TS);

16.	SVR timelines in hepatitis - C irrespective of viral genotype: An Indian perspective.
	Sagar, Nambaru Vidya (NV);Goyal, Anamika (A);Raj, Abhishek (A);Chandra, Subhash (S);Gupta, Upendra Nath (UN);Agrawal, Prabhat (P);Gupta, Rajat (R);Agrahari, Rahul (R);

17.	Acceptability and usability of oral fluid HCV self-testing among health-facility users from Brazil: a cross-sectional study of 685 participants.
	Perazzo, Hugo (H);Villela-Nogueira, Cristiane (C);Gomes, Maria K (MK);Daher, Andre (A);Siqueira-do-Valle, Cristiane (C);Zukeram, Ketiuce (K);Ferreira, Ana Cristina G (ACG);Tonini, Karen Cristine (KC);de Almeida, Elton Carlos (EC);Cardoso, Sandra W (SW);Grinsztejn, Beatriz (B);Veloso, Valdilea G (VG);

18.	Pilot Findings From the First Legalized Mobile Retail Pharmacy Clinic in the United States for Infectious Disease Treatment and Prevention Tailored to Reach People Who Use Drugs.
	Tarfa, Adati (A);Di Paola, Angela (A);Frank, Cynthia A (CA);Schultheis, Alysse M (AM);Brooks, Ralph (R);Shenoi, Sheela V (SV);Springer, Sandra A (SA);

19.	Association between hepatitis C virus infection and rheumatoid arthritis: a nationwide cross-sectional study.
	Tang, Lin (L);Zhang, Lei (L);Ding, Zhonghai (Z);Xu, Wenying (W);Liu, Yu (Y);Yu, Zhenghong (Z);

20.	Comprehensive Care for People Who Use Drugs: Combining Infectious Diseases Services, Harm Reduction, and Primary Care.
	Knodle, Ryan D (RD);Messmer, Sarah E (SE);Murphy, Albert L (AL);Smith, Renata O (RO);Huyck, Michael (M);Cotler, Karen (K);Jimenez, Antonio D (AD);Mayer, Stockton M (SM);

21.	Getting to full disclosure: HCV testing and status disclosure behaviors among PWID and their injecting partners.
	Scarpetta, Maia (M);Kanner, Rachel (R);Menezes, Neia Prata (NP);McDonell, Claire C (CC);Bruneau, Julie (J);Page, Kimberly (K);Morris, Meghan D (MD);

22.	Approaches to Offering Hepatitis C Treatment at Syringe Services Programs in the United States: A Scoping Review.
	Yoder, Theodore (T);Hirose, Kyoko (K);Tsui, Judith I (JI);Feinberg, Judith (J);Hagan, Holly (H);Pho, Mai T (MT);Rowan, Sarah E (SE);

23.	Enhancing public health surveillance: SARIMAX model incorporating Baidu search index for HCV prediction in China.
	Ning, Huan (H);Lan, Yingji (Y);Huang, Qianqian (Q);Luo, Tingyan (T);Yang, Jing (J);Zhou, Jie (J);Li, Zhuoxin (Z);Cui, Ping (P);Liang, Hao (H);Huang, Jiegang (J);

24.	Lytic bone lesion of the skull as a rare manifestation of hepatocellular carcinoma: a case report.
	Wael, Sherif (S);Hamdy, Omar (O);Yasser, Mohamed (M);Elmandrawi, Sara (S);Mostafa, Mai (M);Mohammed, Nouran (N);Elghrieb, Ahmed (A);

25.	Evaluation of an anti-HCV chemiluminescence assay: Enhancing diagnostic accuracy and reducing false positives in hepatitis C screening.
	Zheng, Qingyuan (Q);He, Yong (Y);Zhu, Quanjing (Q);Wang, Chi (C);Nie, Xin (X);

Subscribe